Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2008
04/16/2008EP1911447A1 Eye drop preparation comprising xanthan gum and terpenoid
04/16/2008EP1911444A1 Drug-containing coated fine particle for intrabuccally disintegrating preparation and method of producing the same
04/16/2008EP1910575A2 Immunohistochemistry detection method
04/16/2008EP1910407A2 Mutated pseudomonas exotoxins with reduced antigenicity
04/16/2008EP1909858A2 Hydrogel
04/16/2008EP1909848A2 HMGCoA REDUCTASE INHIBITOR CODRUGS AND USES THEREOF
04/16/2008EP1909847A2 Polymers having covalently bound therapeutic agents
04/16/2008EP1909846A2 Triazole-containing releasable linkers, conjugates thereof, and methods of preparation
04/16/2008EP1909845A2 N,n-bis-(2-hydroxyethyl) glycine amide as linker in polymer conjugated prodrugs
04/16/2008EP1909844A1 Topical formulations containing sporopollenin
04/16/2008EP1909843A2 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field
04/16/2008EP1909842A2 Improved botulinum toxin compositions
04/16/2008EP1909841A2 Vaginal treatment composition
04/16/2008EP1909840A1 Medicated gauze
04/16/2008EP1909839A1 Stabilizers for veterinary vaccines
04/16/2008EP1909838A2 Formulations that inhibit protein aggregation
04/16/2008EP1909775A2 Formulation of radioprotective alpha, beta unsaturated aryl sulfones
04/16/2008EP1909772A1 Transdermal drug delivery formulation
04/16/2008EP1909757A2 Oral liquid losartan compositions
04/16/2008EP1909756A1 Pharmaceutical formulations of endo-n-(9- methyl-9-azabicyclo[3 .3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride
04/16/2008EP1909755A2 Cyclodextrin nanotechnology for ophthalmic drug delivery
04/16/2008EP1909689A2 Drug-containing implants and methods of use thereof
04/16/2008EP1909567A1 Modified inorganic materials
04/16/2008EP1572154A4 Medical devices employing novel polymers
04/16/2008EP1545563B1 Composition and method for use in intestinal cleansing procedures
04/16/2008EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers
04/16/2008EP1509255B1 Methods and compositions for intravesical therapy of bladder cancer
04/16/2008EP1476032B1 Coenzyme q10 formulation
04/16/2008EP1467771B1 Mycobacterial vaccine
04/16/2008EP1401404B1 Method of encapsulating an active substance
04/16/2008EP1343823B1 Antithrombotic von willebrand factor (vwf) collagen bridging blockers
04/16/2008EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
04/16/2008EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them
04/16/2008EP1100460B1 A moldable solid delivery system
04/16/2008EP1026945B1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
04/16/2008CN101163789A Highly porous polymeric materials comprising biologically active molecules via covalent grafting
04/16/2008CN101163508A Integration of meningococcal conjugate vaccination
04/16/2008CN101163507A Process for the preparation of polymer conjugates
04/16/2008CN101163506A Polymer-von willebrand factor-conjugates
04/16/2008CN101163500A Composition for adjuvant containing poly-gamma-glutamic acid
04/16/2008CN101163486A Use of azithromycin for the production of a medicament for treatment of ocular infections
04/16/2008CN101161290A Beta-elemi alkene polyglycol amine derivant as well as its synthesis method and purpose
04/16/2008CN101161289A Water-solubility carrier
04/16/2008CN101161257A Corydalis total alkali clathrate, its preparing method and application
04/16/2008CN101161250A A novel enteron pharmaceutical preparation and its preparing method
04/16/2008CN101161247A Potassium muriate stomach-inner retention floationg type slow release tablet prepared with shuck powder as carrier
04/16/2008CN101161244A Nimodipine tablet and its preparing method
04/16/2008CN101161242A A explosive core composition of controlled release administer drug and controlled release preparation as well as its preparing method
04/16/2008CN101161241A Technique of preparing amlodipine besylate tablets
04/16/2008CN101161239A PLGA Gemcitabine sustained-release microsphere and its preparing method
04/16/2008CN101161238A A lipid nanometer microcapsule based on phospholipids and method for preparing the same
04/16/2008CN101161237A Steady cisplatin element lipoid plastid and method for preparing the same
04/16/2008CN101161236A Method of producing drug-carrying nanometer particle of duplicate flocculation technics in microemulsion
04/16/2008CN101161235A Dasatini sustained-release implants for treating entity knub
04/16/2008CN101161234A Erlotinib sustained-release implants for treating entity knub
04/16/2008CN101161228A Solid cosmetic and therapeutic compositions applicable to the human skin and gellable on contact with water
04/16/2008CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist
04/16/2008CN100381175C Microemulsion formulation and its preparation process
04/16/2008CN100381173C Antitumor agents comprising a targeting portion and an immune response triggering portion
04/16/2008CN100381172C Treating prostate cancer with anti-ErbB2 antibodies
04/16/2008CN100381117C Edible coating composition
04/15/2008US7358379 Steroid conjugates, preparation thereof and the use thereof
04/15/2008US7358284 Particulate acellular tissue matrix
04/15/2008US7358226 The localized, targeted delivery of a drug or contrast agent for imaging by administering and concentrating a carrier by exposing it to a radiation force generated by ultrasound waves at a frequency and pressure combination; rupturing;affecting tissue permeability or altering cell physiology
04/15/2008US7357949 Microcapsule with average diameter of </= 2000 mu; inorganic antimicrobial agent encapsulated within a hydrophilic polymer
04/15/2008US7357948 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
04/15/2008US7357946 Uses for cellulose-containing aggregates
04/15/2008US7357944 Liposomal analgesic drug compositions prepared in GMV using an ammonium sulfate gradient
04/15/2008US7357943 Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
04/15/2008US7357941 implanting matrix for bioactive material which is biocompatible porous forms of beta -tricalcium phosphate granules support the development of new bone throughout its structural form, together with bone morphogenic protein as bioactive material
04/15/2008US7357936 immunostimulant (3-de-O-acylated monophosphoryl lipid A) adsorbed onto metallic salt (aluminium hydroxide or aluminium phosphate); second salt with antigen which elicits immune response to polypeptide or pathogen; Hepatitis, human papilloma virus
04/15/2008US7357930 Methods and formulations for targeting infectious agents bearing host cell proteins
04/15/2008US7357925 Method for treating disorders and diseases treatable with human fibroblast interferon
04/15/2008US7357922 Microemulsion containing alkanolammonium salts of fatty alcohol sulfates and/or alkylpolyalkyleneglycoethersulfates
04/15/2008US7357336 Generation of therapeutic microfoam
04/15/2008CA2566590C Cronotherapeutic diltiazem formulation and the administration thereof
04/15/2008CA2454027C Residual solvent extraction method and microparticles produced thereby
04/15/2008CA2401910C Hydrophilic molecular disperse solutions of carvedilol
04/15/2008CA2280629C Carotenoid formulations, comprising a mixture of .beta.-carotene, lycopene and lutein
04/15/2008CA2269655C Peptide compositions with growth factor-like activity
04/15/2008CA2215800C Self-emulsifying formulation producing a positively charged emulsion
04/10/2008WO2008043081A2 Liquid chalcogenide compositions and methods of manufacturing and using the same
04/10/2008WO2008042619A2 Self-preserved aqueous pharmaceutical compositions
04/10/2008WO2008042436A2 Biomarkers and assays for the treatment of cancer
04/10/2008WO2008042218A1 Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
04/10/2008WO2008041774A1 Sustained-release preparation having bone conduction ability
04/10/2008WO2008041740A1 Glutathione preparation and method for production thereof
04/10/2008WO2008041704A1 Controlled release preparation
04/10/2008WO2008041553A1 Tacrolimus sustained-release preparation
04/10/2008WO2008041514A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer
04/10/2008WO2008041246A2 Injectable depot composition and its' process of preparation
04/10/2008WO2008041245A2 Injectable depot composition and it's process of preparation
04/10/2008WO2008040786A1 Comb polymers and use thereof for the production of active or effective ingredient formulations
04/10/2008WO2008040763A1 Pharmaceutical compositions comprising bisphosphonates
04/10/2008WO2008040556A1 Dried reconstituted vesicle formation for pharmaceutical application
04/10/2008WO2008040362A2 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
04/10/2008WO2008040230A1 Consolidant for trauma and ulcer comprising fibronectin
04/10/2008WO2008023378A9 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
04/10/2008WO2008019254A3 Reagents, methods and systems to suppress pro-inflammatory cytokines
04/10/2008WO2008016701A3 Biogenic silica from silica-containing plant material such as rice hulls